Search SNWV
SANUWAVE Health, Inc.
Nasdaq · CIK 1417663
Last close4.82
Daily change+0.20 (4.33%)
10 Years gain-62.99%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SNWV · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
67.7Momentum
n/aAcceleration
n/aConfidence
70.0Annual Revenue16
Quarterly Revenue53
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.3 / 25
Quality5.3 / 25
Capital Efficiency20.0 / 20
Balance Sheet11.7 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM-14.12%OK
Revenue CAGR 3Y41.61%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $44.05M | $33.97M | $4.95M | $3.88M | $1.93M | 77.11% | 11.23% | 4.39% | n/a | 9.08M |
| 2025 FY Dec 31, 2024 | n/a | $24.55M | $3.85M | $2.46M | $1.97M | n/a | n/a | n/a | n/a | 4.46M |
| 2024 FY Dec 31, 2024 | $32.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2024 FY Dec 31, 2023 | $19.26M | $14.36M | -$540,000.00 | -$4.54M | -$4.54M | 74.59% | -2.8% | -23.57% | n/a | 2.12M |
| 2023 FY Dec 31, 2022 | $15.51M | $12.41M | -$8.95M | -$17.17M | n/a | 80.01% | -57.71% | n/a | n/a | 549.47M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $40.93M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-25-038937, 0001628280-25-050280 |
| Revenue Growth TTM | -14.12% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-25-038937, 0001628280-25-050280 |
| Revenue CAGR 3Y | 41.61% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-021443 |
| Revenue CAGR 5Y | 64.76% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-021443 |
| Gross Profit CAGR 3Y | 39.88% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-021443 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-054393 |
| Current Ratio | 1.28x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $4.76 | Revenue / Diluted Shares | OK | 0001628280-25-038937, 0001628280-25-050280 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001628280-26-021443 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001628280-26-054393 |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |